Last price paid | 1.39 | |
Change | +4.51% [ +0.06 ] | |
Last traded volume | n.a. Unit | |
Cumulative volume | n.a. Unit | |
Date/time | 24.06.2024 17:20 |
Fixing | n.a. |
Settlement date | 05.12.2023 |
Last trading | n.a. |
Final fixing | n.a. |
Currency redemption | CHF |
Perf. since issue | +76.58% |
Year to date (YTD) | +27.52% |
1 month | -13.66% |
3 months | -9.15% |
1 year | n.a. |
3 years | n.a. |
Issue price | 0.79 |
Underlying price on issue | 24.90 |
Premium | 0.00% |
Premium p.a. | n.a. |
Leverage | n.a. |
Implied volatility | n.a. |
ISIN | CH1281046412 |
Symbol | IUBNXZ |
Security | 128104641 |
Exchange | SIX Structured Products |
Currency | CHF |
Expiry | n.a. |
Underlying | UBS Group N, CH0244767585 |
Underlying ISIN | CH0244767585 |
Funding level | 21.860700 |
Stop-loss level | 22.671900 |
Distance to stop-loss level | 17.20% |
Long/Short type | Long |
Subscription ratio | 4.00 |
Issuer | Zürcher Kantonalbank |
Exercise type | n.a. |
Minimum execution | n.a. |
Value day | 01.12.2023 |
Premium | 0.21% |
Premium p.a. | n.a. |
Leverage | 4.91 |
Moneyness | in-the-money |
Leverage | n.a. |
Delta | n.a. |
Intrinsic value | 5.522000 |
Break-even | n.a. |
SSPA value at risk | n.a. |
SSPA risk rating | n.a. |
SSPA derivative category | Leverage |
SSPA code | Mini future (2210) |
Name | Price |
---|---|
NOVARTIS N | 96.01 |
Lonza Group | 487.10 |
GEBERIT N | 547.40 |
Alcon AG | 80.80 |
Partners Group Ho... | 1'171.00 |
Name | Price |
---|---|
Holcim | 78.78 |
Swiss Life Hldg | 656.00 |
Swiss Re | 113.10 |
ABB Ltd | 50.12 |
Sika AG | 257.20 |